The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess ... in achieving debridement and preparing the wound bed for VLUs healing. With an adaptive design, the global ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

and inflammation, in view of these binding capacities to various RAR receptors. Tazarotene down-regulates the abnormal expression of keratinocytes, epidermal growth factor receptor, and ...

Oleogel-S10 is an effective and well-tolerated long-term treatment for epidermolysis bullosa, including patients with severe forms of the disease.

11th Day,3rd Day,Accelerated Wound Healing,Acute Inflammation,Antimicrobial Properties,Bacterial Mixture,Chitosan,Chronic Inflammation,Copper Nanoparticles,Early ...